RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 36 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,022,173 | +9.7% | 155,819 | 0.0% | 0.16% | -22.7% |
| Q1 2023 | $931,798 | +156.7% | 155,819 | 0.0% | 0.21% | +139.8% |
| Q4 2022 | $363,059 | -30.3% | 155,819 | 0.0% | 0.09% | -15.4% |
| Q3 2022 | $521,000 | +6.1% | 155,819 | -16.0% | 0.10% | +15.6% |
| Q2 2022 | $491,000 | -10.1% | 185,597 | 0.0% | 0.09% | +25.0% |
| Q1 2022 | $546,000 | -63.5% | 185,597 | +6.1% | 0.07% | -67.7% |
| Q4 2021 | $1,497,000 | +14.9% | 175,000 | 0.0% | 0.22% | +142.4% |
| Q3 2021 | $1,303,000 | – | 175,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |